Literature DB >> 19176628

Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.

Susan J Morris1, Keith N Leppard.   

Abstract

Adenoviruses express up to 20 distinct mRNAs from five major late transcription unit (MLTU) regions, L1 to L5, by differential splicing and polyadenylation of the primary transcript. MLTU expression is regulated at transcriptional and posttranscriptional levels. The L4-33K protein acts as a splicing factor to upregulate several MLTU splice acceptor sites as the late phase progresses. The L4 region also expresses a 22K protein whose sequence is related to the sequence of L4-33K. L4-22K is shown here also to have an important role in regulating the pattern of MLTU gene expression. An adenovirus genome containing a stop codon in the L4-22K open reading frame expressed low levels of both structural and nonstructural late proteins compared to the wild-type (wt) adenovirus genome; a decrease in intermediate proteins, IVa2 and IX, was also observed. However, early protein synthesis and replication were unaffected by the absence of L4-22K. Intermediate and late protein expression was restored to wt levels by L4-22K expressed in trans but not by L4-33K. Increased MLTU promoter activity, resulting from stabilization of the transcriptional activator IVa2 by L4-22K, made a small contribution to this restoration of late gene expression. However, the principal effect of L4-22K was on the processing of MLTU RNA into specific cytoplasmic mRNA. L4-22K selectively increased expression of penton mRNA and protein, whereas splicing to create penton mRNA is known not to be increased by L4-33K. These results indicate that L4-22K plays a key role in the early-late switch in MLTU expression, additional to and distinct from the role of L4-33K.

Mesh:

Substances:

Year:  2009        PMID: 19176628      PMCID: PMC2655540          DOI: 10.1128/JVI.02455-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  The role of the L4 33K gene in adenovirus infection.

Authors:  S P Fessler; C S Young
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

Review 2.  Update on adenovirus and its vectors.

Authors:  W C Russell
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

3.  Truncation of the human adenovirus type 5 L4 33-kDa protein: evidence for an essential role of the carboxy-terminus in the viral infectious cycle.

Authors:  R L Finnen; J F Biddle; J Flint
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

Review 4.  Genetic content and evolution of adenoviruses.

Authors:  Andrew J Davison; Mária Benkő; Balázs Harrach
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

5.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

Authors:  C Chartier; E Degryse; M Gantzer; A Dieterle; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Identification of a cellular repressor of transcription of the adenoviral late IVa(2) gene that is unaltered in activity in infected cells.

Authors:  H J Lin; S J Flint
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

7.  Role for the adenovirus IVa2 protein in packaging of viral DNA.

Authors:  W Zhang; J A Low; J B Christensen; M J Imperiale
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Exploitation of the Herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role.

Authors:  S J Morris; H Smith; C Sweet
Journal:  Arch Virol       Date:  2002-05       Impact factor: 2.574

9.  Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products.

Authors:  Daniel C Farley; Jason L Brown; Keith N Leppard
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein.

Authors:  Katherine J Lethbridge; Gillian E Scott; Keith N Leppard
Journal:  J Gen Virol       Date:  2003-02       Impact factor: 3.891

View more
  20 in total

1.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Adenovirus late-phase infection is controlled by a novel L4 promoter.

Authors:  Susan J Morris; Gillian E Scott; Keith N Leppard
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging.

Authors:  Hsin-Chieh Ma; Patrick Hearing
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

4.  The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection.

Authors:  Kai Wu; Diana Orozco; Patrick Hearing
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging.

Authors:  Kai Wu; Diana Guimet; Patrick Hearing
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

6.  The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome.

Authors:  Diana Guimet; Patrick Hearing
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

7.  The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts.

Authors:  Yi-Chieh Perng; Zhikang Qian; Anthony R Fehr; Baoqin Xuan; Dong Yu
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

8.  Identification and characterization of a DNA binding domain on the adenovirus IVa2 protein.

Authors:  Joan B Christensen; Sean G Ewing; Michael J Imperiale
Journal:  Virology       Date:  2012-08-09       Impact factor: 3.616

9.  Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response.

Authors:  Zeenah Atwan; Jordan Wright; Andrew Woodman; Keith N Leppard
Journal:  J Gen Virol       Date:  2016-05-23       Impact factor: 3.891

10.  Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange.

Authors:  Susan J Morris; Daniel C Farley; Keith N Leppard
Journal:  BMC Biotechnol       Date:  2010-12-23       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.